急性呼吸窘迫综合征的可归因死亡率:系统综述、荟萃分析及基于目标最小损失估计的生存分析
p<0.001)。对3个ICU队列1203例患者中658例脓毒症患者进行生存分析,控制混杂因素后ARDS使死亡率增加15%(95%CI 3%-26%;p=0.015),重度与中度ARDS死亡率显著增加,轻度无显著增加。结论认为ARDS与死亡存在直接因果关联。
要点
- 合并ARDS的危重症患者死亡率显著升高,汇总风险比为2.48(95%CI 1.86-3.30)。
- 脓毒症患者中,ARDS使死亡率增加15%(95%CI 3%-26%),支持直接因果关联。
- 重度与中度ARDS死亡率显著增加,轻度ARDS未观察到显著增加。
核心结论
- ARDS与死亡存在直接因果关联,其可归因死亡率在脓毒症患者中为15%(95%CI 3%-26%;p=0.015)。
- 持续资助ARDS预防试验具有潜在生存获益价值。
研究设计与样本
- 首先对报告匹配基础危险因素的合并/未合并ARDS危重症患者死亡率的观察性研究进行系统综述与荟萃分析。
- 随后对3个ICU队列前瞻性收集的患者个体数据进行生存分析,采用目标最小损失估计的因果推断方法。
- PROSPERO注册号CRD42017078313。
主要发现
- 荟萃分析中,合并ARDS患者死亡率高于未合并者(风险比2.48,95%CI 1.86-3.30;p<0.001)。
- ARDS与死亡率的关联在创伤中数值上强于脓毒症。
- 生存分析控制混杂因素后,ARDS使脓毒症患者死亡率增加15%(95%CI 3%-26%;p=0.015)。
- 重度ARDS死亡率增加23%(95%CI 3%-44%;p=0.028),中度增加16%(95%CI 2%-31%;p=0.031),轻度ARDS无显著增加。
临床怎么用
- 临床中应将ARDS视为独立增加死亡风险的病因,而非仅伴随标志。
- 对中重度ARDS患者应加强死亡风险评估与干预。
- 该可归因死亡率数据可用于论证ARDS预防研究的投入价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although acute respiratory distress syndrome (ARDS) is associated with high mortality, its direct causal link with death is unclear. Clarifying this link is important to justify costly research on prevention of ARDS. OBJECTIVE: To estimate the attributable mortality, if any, of ARDS. DESIGN: First, we performed a systematic review and meta-analysis of observational studies reporting mortality of critically ill patients with and without ARDS matched for underlying risk factor. Next, we conducted a survival analysis of prospectively collected patient-level data from subjects enrolled in three intensive care unit (ICU) cohorts to estimate the attributable mortality of critically ill septic patients with and without ARDS using a novel causal inference method. RESULTS: In the meta-analysis, 44 studies (47 cohorts) involving 56 081 critically ill patients were included. Mortality was higher in patients with versus without ARDS (risk ratio 2.48, 95% CI 1.86 to 3.30; p<0.001) with a numerically stronger association between ARDS and mortality in trauma than sepsis. In the survival analysis of three ICU cohorts enrolling 1203 critically ill patients, 658 septic patients were included. After controlling for confounders, ARDS was found to increase the mortality rate by 15% (95% CI 3% to 26%; p=0.015). Significant increases in mortality were seen for severe (23%, 95% CI 3% to 44%; p=0.028) and moderate (16%, 95% CI 2% to 31%; p=0.031), but not for mild ARDS. CONCLUSIONS: ARDS has a direct causal link with mortality. Our findings provide information about the extent to which continued funding of ARDS prevention trials has potential to impart survival benefit. PROSPERO REGISTRATION NUMBER: CRD42017078313.
引用
- Torres LK, Hoffman KL, Oromendia C, et al. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation. Thorax. 2021. PMID: 33863829. doi:10.1136/thoraxjnl-2020-215950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。